Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-014726
Filing Date
2013-11-14
Accepted
2013-11-14 09:03:20
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ombp20130930_10q.htm 10-Q 606209
2 EXHIBIT 10.1 ex10-1.htm EX-10 94760
3 EXHIBIT 10.2 ex10-2.htm EX-10 88608
4 EXHIBIT 31.1 ex31-1.htm EX-31 9475
5 EXHIBIT 31.2 ex31-2.htm EX-31 8648
6 EXHIBIT 32.1 ex32-1.htm EX-32 6700
  Complete submission text file 0001437749-13-014726.txt   3023879

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS ombp-20130930.xml EX-101.INS 281268
8 EXHIBIT 101.SCH ombp-20130930.xsd EX-101.SCH 30166
9 EXHIBIT 101.CAL ombp-20130930_cal.xml EX-101.CAL 10661
10 EXHIBIT 101.DEF ombp-20130930_def.xml EX-101.DEF 153129
11 EXHIBIT 101.LAB ombp-20130930_lab.xml EX-101.LAB 225681
12 EXHIBIT 101.PRE ombp-20130930_pre.xml EX-101.PRE 155681
Mailing Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111
Business Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111 (303) 867-3415
OMNI BIO PHARMACEUTICAL, INC. (Filer) CIK: 0001389870 (see all company filings)

EIN.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-52530 | Film No.: 131216996
SIC: 2836 Biological Products, (No Diagnostic Substances)